LabInCube Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 66

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $10M

  • Investors
  • 9

LabInCube General Information

Description

Developer of drug-delivery devices and pharmaceutical products designed to control the storage and release of therapeutic substances. The company offers drug storage systems that regulate molecular spacing to manage the protection, absorption, and sustained release of active ingredients, enabling pharmaceutical manufacturers to develop controlled drug-delivery products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 304-C2, Building A, 45 Yangcheong 4-gil
  • Ochang-eup, Cheongwon-gu, Chungbuk
  • Cheongju
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Room 304-C2, Building A, 45 Yangcheong 4-gil
  • Ochang-eup, Cheongwon-gu, Chungbuk
  • Cheongju
  • South Korea
+82

LabInCube Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LabInCube Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 18-Mar-2026 $10M Completed Generating Revenue
5. Later Stage VC (Series A) 05-Jan-2026 Completed Generating Revenue
4. Early Stage VC (Series A) 01-Apr-2024 Completed Startup
3. Accelerator/Incubator 01-Mar-2022 Completed Startup
2. Seed Round 01-Aug-2021 Completed Startup
1. Accelerator/Incubator Completed Startup
To view LabInCube’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

LabInCube Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LabInCube Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kingo Investment Partners Venture Capital Minority
Meta Biomed Corporation Minority
BNH Investment Venture Capital Minority
JKP Partners Venture Capital Minority
Korea Investment Partners Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

LabInCube FAQs

  • When was LabInCube founded?

    LabInCube was founded in 2021.

  • Where is LabInCube headquartered?

    LabInCube is headquartered in Cheongju, South Korea.

  • What is the size of LabInCube?

    LabInCube has 66 total employees.

  • What industry is LabInCube in?

    LabInCube’s primary industry is Drug Discovery.

  • Is LabInCube a private or public company?

    LabInCube is a Private company.

  • What is LabInCube’s current revenue?

    The current revenue for LabInCube is .

  • How much funding has LabInCube raised over time?

    LabInCube has raised $13.9M.

  • Who are LabInCube’s investors?

    Kingo Investment Partners, Meta Biomed, BNH Investment, JKP Partners, and Korea Investment Partners are 5 of 9 investors who have invested in LabInCube.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process